Beyond angioplasty: Novel developments in interventional cardiology

Internal Medicine Journal

Volumn 32, Issue 9, 2002, Pages 470-474

  Lowe, H C ^a   Burkoff, D ^b   Khachigian, L M ^c   MacNeill, B D ^a   Hayase, M ^a   Oesterle, Stephen N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Howard Hughes Medical Institute   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Coating; Gene; Myocardial; Revascularization stent

Indexed keywords

CARDIOVASCULAR AGENT; PACLITAXEL; RAPAMYCIN; RECOMBINANT DNA;

ANGIOPLASTY; CLINICAL TRIAL; CORONARY STENT; DRUG DELIVERY SYSTEM; GENE THERAPY; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEART CATHETERIZATION; HUMANS; MYOCARDIAL REVASCULARIZATION; STENTS;

EID: 0036042729     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00261.x     Document Type: Review

References (22)

1. Percutaneous in situ coronary venous arterialization. Report of the first human catheter-based coronary artery bypass
2. Direct myocardial revascularization and angiogenesis-how many patients might be eligible?
3. Myocardial revascularisation by laser
4. Revascularization of the heart by laser
5. Percutaneous transmyocardial laser revascularisation for severe angina: The PACIFIC randomised trial
6. Combined percutaneous Biosense-guided laser revascularization and coronary intervention
7. Therapeutic angiogenesis for ischemic Cardiovascular disease
8. Bone marrow cells regenerate infarcted myocardium
9. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia
10. Direct coronary artery perfusion from the left ventricle
11. In-stent restenosis: Current status and future strategies
12. Nucleic acid based strategies as potential therapeutic tools: Mechanistic considerations and implications to restenosis
13. Catalytic oligode-oxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis
14. Gene therapy for restenosis: Promise and perils
15. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
16. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries
17. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up
18. Living the dream of no restenosis
19. Coated stents
20. Therapeutic angiogenesis for coronary artery disease
21. Visualization of tissue prolapse between coronary stent struts by optical coherence tomography: Comparison with intravascular ultrasound